AN2 Therapeutics Inc.
ANTX | NASDAQ
$4.53
-$0.16 (-3.41%)
At close: Oct 30, 2026, 4:00 PM ET
$4.53
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 5:27 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.98 | -0.80 | -7.48 | -3.42 | -10.27 | -19.74 |
PEG Ratio | 0.03 | 0.02 | 4.17 | -0.04 | -0.11 | -0.12 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.65 | 0.50 | 3.88 | 1.53 | 4.66 | 104.91 |
P/FCF Ratio | -1.15 | -0.84 | -9.07 | -4.37 | -14.09 | -53.80 |
P/OCF Ratio | -1.15 | -0.84 | -9.07 | -4.37 | -14.09 | -53.80 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0 | n/a | n/a |
Quick Ratio | 6.87 | 8.43 | 7.87 | 13.72 | 17.70 | 2.90 |
Current Ratio | 6.87 | 8.43 | 7.87 | 13.72 | 17.70 | 2.90 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -82.22 | n/a | n/a |
Return on Equity | -66.29% | -62.70% | -51.91% | -42.94% | -34.80% | -494.47% |
Return on Assets | -56.78% | -55.73% | -46.66% | -39.93% | -32.98% | -321.28% |
Return on Invested Capital | -71.59% | -66.65% | -55.84% | -44.29% | -34.84% | -262.49% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ANTX